Triiodothyronine + baicalein
1 paper4 findings
- 1 lab in 1 country
- Funders: Anusandhan National Research Foundation and 4 more
- Animals1
Outcomes
3Dyslipidemia
downin mice1
1 study
Dyslipidemia
downin mice1
Triiodothyronine + baicalein decreases dyslipidemia in mice.
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalsadenine-induced CKD
Biogerontology26 May 2025
Renal fibrosis
downin mice1
1 study
Renal fibrosis
downin mice1
Triiodothyronine + baicalein decreases renal fibrosis in mice.
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalsadenine-induced CKDkidney
Biogerontology26 May 2025
KL
upin mice1
1 study
KL
upin mice1
Triiodothyronine + baicalein increases KL in mice.
“Combined T3 and BAI treatment significantly increased Klotho levels, surpassing individual effects”
Animalsadenine-induced CKDkidney
Biogerontology26 May 2025
Associations
1Cardiovascular disease
downin mice1
1 study
Cardiovascular disease
downin mice1
Triiodothyronine + baicalein lowers the risk of cardiovascular disease in mice.
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalsadenine-induced CKD
Biogerontology26 May 2025